| ViewRay Secures $30,000,000 New Financing | VentureDeal | 12/17/13 | Detroit Ann Arbor |
| Seragon Pharmaceuticals Obtains $30,000,000 Series A Financing | VentureDeal | 10/18/13 | San Diego |
| Versartis Garners $20,000,000 Series D Financing Round | VentureDeal | 10/08/13 | San Francisco |
| East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More | Ben Fidler | 10/04/13 | Boston |
| Loxo Oncology Lands $33,000,000 Series A Funding Round | VentureDeal | 10/04/13 | New York |
| 5 Things Biotechs Should Do to Take Advantage of The Boom | Dennis Purcell | 09/05/13 | New York |
| Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing | Steve Dickman | 08/16/13 | Boston |
| Esperion Therapeutics Secures $33,000,000 New Funding Round | VentureDeal | 04/25/13 | Detroit Ann Arbor |
| T2 Biosystems Obtains $40,000,000 Series E Funding | VentureDeal | 03/28/13 | Boston |
| Versartis Secures $25,000,000 Series C Funding | VentureDeal | 01/15/13 | San Francisco |
| Mayleben Ends Short-Lived Retirement to Lead Esperion | Sarah Schmid Stevenson | 01/04/13 | Detroit Ann Arbor |
| San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit | Bruce V. Bigelow | 11/09/12 | San Diego |
| San Diego’s Ambit Biosciences Raises $25M to Advance Leukemia Drug | Bruce V. Bigelow | 11/06/12 | San Diego |
| Ambit Biosciences Obtains $50,000,000 New Funding | VentureDeal | 11/06/12 | San Diego |
| Can New York Take on Boston, California as a Biotech Hub? | Catherine Arnst | 10/11/12 | New York |
| San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More | Bruce V. Bigelow | 10/05/12 | San Diego |
| Reinventing Biotech’s Biz Model for NY: Issues for Our Oct. 4 Event | Robert Buderi | 10/01/12 | New York |
| Aragon Pharmaceuticals Receives $49,999,988 Series D Round | VentureDeal | 09/26/12 | San Diego |
| Almost Time for Face Time with Sam Waksal, Kevin Kinsella, and More | Rebecca Zacks | 09/20/12 | New York |
| NYC Bio Luminaries to Gather Oct. 4th for Xconomy Xchange | Arlene Weintraub | 09/04/12 | New York |
| An Insider’s View on Raising Money from Life Sciences VCs | Dennis Purcell | 08/21/12 | New York |
| Fall Xconomy Xchange to Focus on Reinventing Biotech for the Big Apple | Arlene Weintraub | 07/31/12 | New York |
| Who’s Still Active Among the Early-Stage Biotech VCs? | Luke Timmerman | 07/02/12 | National |
| San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers | Bruce V. Bigelow | 03/06/12 | San Diego |
| Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round | VentureDeal | 03/06/12 | San Diego |
| New York’s Venture Emergence: The Photos | Robert Buderi | 02/03/12 | New York |
| Global Healthcare | Dennis Purcell | 01/18/12 | New York |
| Early Pharma Partnership Proves Key to Armgo’s Startup Success | Arlene Weintraub | 12/22/11 | New York |
| Startups and VCs to Gather for Xconomy’s New York Venture Emergence Forum | Arlene Weintraub | 11/30/11 | New York |
| Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News | Erin Kutz | 08/17/11 | Boston |
